NCT00314561
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +8 more
- Locations
-
- Korea University Anam Hospital Seoul, South Korea
Clinical trial condition
Insulin Resistance
Explore clinical trials studying Insulin Resistance. Study availability and eligibility vary by location and protocol.
1,384 public trials
163 recruiting studies
Insulin Resistance trial results
NCT00230919
- Conditions
- Body Weight, Body Weight Changes, Glucose Metabolism Disorders, +12 more
- Locations
-
- Ulleval University Hospital, dep. of preventive cardiology Oslo, Norway
Completed
Assessing The Treatment Effect in Metabolic Syndrome Without Perceptible diabeTes (ATTEMPT)
NCT00416741
- Conditions
- Body Weight, Cardiovascular Diseases, Diabetes Mellitus, +18 more
- Locations
-
- Hellenic Atherosclerosis Society Thessaloniki, Greece
Completed
Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months
NCT00711737
- Conditions
- Anxiety Disorders, Depressive Disorder, Depressive Disorder, Major, +11 more
- Locations
-
- Changi General Hospital Singapore
Completed
Weight Loss Improves Renal Hemodynamics
NCT01356394
- Conditions
- Body Weight, Chronic Disease, Chronic Kidney Disease, +22 more
- Locations
-
- NIEPEN Juiz de Fora, Minas Gerais, Brazil
NCT00664742
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +3 more
- Locations
-
- Götzepe Education and Research Hospital Istanbul, Turkey (Türkiye)
Completed
Effects of Docosahexaenoic Acid (DHA) on Children With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00885313
- Conditions
- Body Weight, Digestive System Diseases, Fatty Liver, +19 more
- Locations
-
- Bambino Gesù Hospital and Research Institute Rome, Italy
NCT00111358
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- Mass General Hospital Boston, Massachusetts, United States
NCT00110422
- Conditions
- Cardiovascular Diseases, Glucose Metabolism Disorders, Hyperinsulinism, +6 more
- Locations
-
- Local Institution Angers, France
- Local Institution Nantes, France
- Local Institution Tiercé, France
- Local Institution Hanover, Germany
NCT00797316
- Conditions
- Cardiovascular Diseases, Glucose Metabolism Disorders, Hyperinsulinism, +6 more
- Locations
-
- Novartis Pharmaceuticals East Hanover, New Jersey, United States